when

Latest
Archive

by source

All Sources
Sources Page

department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Jobs
News

Hubs

Topics
Patent cliff
Publications

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
search

the cabinet

Drugs

8,127 products tracked

★ save view ↓export CSV

phase

all Marketed Phase 3 Phase 2 Phase 1 Preclinical

sort

catalysts recent name

therapeutic area

all Oncology1831 Infectious Disease718 Cardiology425 Pulmonology396 Immunology371 Ophthalmology368 Dermatology300 Women's Health131

Phase 1
DXDRGB-05
Coronavirus Disease 2019 (COVID-19) Dx&Vx
DYANAVEL XR
DYANAVEL XR (AMPHETAMINE)
1 INDICATIONS AND USAGE DYANAVEL XR is indicated for the…$TRAW Traws Pharma, Inc.
DYNACIN
DYNACIN (MINOCYCLINE HYDROCHLORIDE)
no indication Alvogen Inc
Preclinical
DYNE-302

page 87 of 271

Facioscapulohumeral Muscular Dystrophy (FSHD)

$DYN Dyne Therapeutics, Inc.

Preclinical

Osteoarthritis Darnatein

Marketed

Daptomycin Nichi-Iko

Bacterial Endocarditis Sagent Pharmaceuticals Inc

Marketed

Bacteremia Baxter Healthcare Corp

Marketed

Daunorubicin Hydrochloride Hikma

Cerubidine (daunorubicin hydrochloride)

Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leuk… Hikma Pharmaceuticals USA Inc

Phase 2

Adenoid Cystic Carcinoma (ACC)$INDP Indaptus Therapeutics, Inc.

Preclinical

Deep Vein Thrombosis (DVT) Glycan Therapeutics Inc

Phase 1

Non-Small Cell Lung Cancer Immunocell Therapeutics Inc

Phase 1

Secondary Hyperparathyroidism Novadiol Inc

Marketed

Gammagard Liquid ERC (immune globulin (human))

Primary Immune Deficiency (PID) Takeda Pharmaceuticals USA Inc

Marketed

Elestrin (estradiol)

Vasomotor Symptoms of Menopause (Hot Flashes) Mylan Specialty LP

Marketed

Clobetasol Propionate Mylan (clobetasol propionate)

Atopic Dermatitis (Atopic Eczema) Mylan Pharmaceuticals Inc

Phase 3

Myasthenia Gravis$RNAC Cartesian Therapeutics, Inc.

Marketed

Desonide Actavis (desonide)

Psoriasis Teva Pharmaceuticals USA Inc

Marketed

Tolterodine Tartrate Teva (tolterodine tartrate)

Overactive Bladder Teva Pharmaceuticals USA Inc

Marketed

Detrol LA (tolterodine tartrate)

Overactive Bladder$VTRS Viatris Inc

Marketed

Dexycu (dexamethasone)

Ocular Inflammation$EYPT EyePoint, Inc.

Phase 1

Diakine-DK210 (EGFR)

Bladder Cancer Deka Biosciences Inc

Marketed

Diclegis ((doxylamine [INN] + pyridoxine hydrochloride))

Emesis (Vomiting) Duchesnay USA Inc

Phase 2

Zicthoru (diclofenac sodium)

Chronic Low Back Pain (CLBP) Hisamitsu Pharmaceutical Co Inc

Marketed

Diflunisal Teva

Osteoarthritis Pain Teva Pharmaceuticals USA Inc

Marketed

Digoxin (digoxin [INN])

Atrial Fibrillation Hikma Pharmaceuticals USA Inc

Marketed

Dilantin (phenytoin)

Partial Seizure$VTRS Viatris Inc

Marketed

Diltiazem Hydrochloride Teva

Diltiazem Hydrochloride

Angina (Angina Pectoris) Teva Pharmaceuticals USA Inc

Marketed

Diovan (valsartan)

Congestive Heart Failure (Heart Failure)$NVS NOVARTIS AG

Marketed

Diovan HCT ((hydrochlorothiazide [INN] + valsartan))

Hypertension$NVS NOVARTIS AG

Preclinical

Solid Tumor RootPath Genomics Inc